BCRX position history
The shares of Biocryst Pharmaceuticals (BCRX) that FARALLON CAPITAL MANAGEMENT, L.L.C. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q3: 48,000 shares, $364K, <0.01% of portfolio, New
- 2025 Q4: 24,000 shares, $187K, <0.01% of portfolio, Reduce −50.0%
- 2026 Q1: 24,000 shares, $228K, <0.01% of portfolio
- 2026 Q2: not held, Exit
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|